NCT01933620
Studies of the Human Microbiome in Clinical Center Patients
Enrolling by Invitation
Not specifiedAges 2+ObservationalNational Institutes of Health Clinical Center (CC)Government-funded
~250 participants
Updated 2026-08-03 on ClinicalTrials.gov
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
The primary endpoint is to accumulate a sufficiently robust body of intestinal microbiome data and clinical and epidemiological metadata to characterize fully the changes in the human microbiota that occur during the course of hospitalization an...
Measured over At completion of study
Conditions
Where it's being run
1 sites across 1 statesMaryland1
Study leadership
- Alison Han, M.D. · PRINCIPAL_INVESTIGATOR · National Institutes of Health Clinical Center (CC)
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Be inpatients in the NIH CC with an expected hospitalization of at least 48 hours beyond the date of referral.
Be 2 years of age or older
Allow storage of tissue samples for future analyses.
Allow genetic testing of body fluids, and tissue specimens.
What this trial measures
- The primary endpoint is to accumulate a sufficiently robust body of intestinal microbiome data and clinical and epidemiological metadata to characterize fully the changes in the human microbiota that occur during the course of hospitalization an...At completion of study
Once sufficient microbiome data and clinical and epidemiological meta data is collected we will be able to fully characterize the changes in the human microbiota that occur during the course if hospitalization